Detalhe da pesquisa
1.
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients.
Nephrol Dial Transplant
; 26(6): 2018-24, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974645
2.
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome.
Hum Vaccin
; 7(6): 613-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21508673
3.
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
Pediatrics
; 127(5): e1161-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21464195
4.
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Vaccine
; 29(8): 1677-82, 2011 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21199699